We use a secure payment system that safeguards your personal information and prevents unauthorized third-party access
J Pediatr 145:555560 Whl E, Haffner D, Offner G, Broyer M, vant Hoff W, Mehls O
The American Gastroenterological Association's 2022 clinical practice guideline on obesity pharmacotherapy, published in Gastroenterology, states: "We suggest using semaglutide 2.4 mg subcutaneous weekly for adults with obesity or overweight with weight-related comorbidities (conditional recommendation, moderate-certainty evidence)." This guideline also notes that pharmacotherapy should accompany, not replace, lifestyle intervention
A structured plan for nutrition, activity, and gradual tapering helps support long-term weight maintenance after treatment ends
Unlike traditional treatments, PT-141 works by directly stimulating sexual desire and arousal in both men and women
My treatment, micro-needling w/PRP